Clinical Management of Low Grade Bladder Tumors

作者: Willem Oosterlinck

DOI: 10.1007/978-1-60761-928-4_11

关键词:

摘要: Low-grade urothelial neoplasms have different behavior and better outcome than higher grade tumors. Noninvasive tumors are the most common bladder cancers. Seventy percent low grade. The incidence is below age of 50 but thereafter it steadily grows. World Health Organization (WHO) 2004 histological classification risk factors described. Cystoscopy method by which papillary detected. Macroscopically, low-grade lesion nicely papillary. Urinary cytology negative in majority useful at first diagnosis to predict high-grade Outpatient fulguration increasingly popular recurrent, Upper tract exploration initial performed not only for detection upper tumors, also hematuria. A complete transurethral resection (TUR) essential prognosis patient. Random biopsies inappropriate. Although TUR eradicates Ta completely they will recur very often. high variability 3-month recurrence rate indicates that incomplete or provokes recurrences. It therefore necessary consider adjuvant therapy all patients. single immediate instillation a chemotherapy agent significantly reduces advocated as standard treatment. need more instillations related prognostic factors. important multiplicity, 3 months, previous rate, size (>3 cm). Bacille Calmette-Guerin (BCG) should be used first-line treatment can second line. Evolution stage does occur less 20% patients over years. progression rare. EUA guidelines control months after advisable picks up resections next delayed 9 months. highest chance 2 years, third year, few thereafter.

参考文章(78)
Hossam M. El-Ganzoury, Samir El-Ghobashy, Tarek R. El-Leithy, Mamdouh M. Roshdy, Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up. Journal of the Egyptian National Cancer Institute. ,vol. 19, pp. 121- 126 ,(2007)
Willem Oosterlinck, Karl-Heinz Kurth, Fritz Schröder, Richard Sylvester, Bernadette Hammond, and Members of the EORTC GU Group, A plea for cold biopsy, fulguration and immediate bladder instillation with Epirubicin in small superficial bladder tumors. Data from the EORTC GU Group Study 30863. European Urology. ,vol. 23, pp. 457- 459 ,(1993) , 10.1159/000474652
Jen S. Pan, Harry K. Slocum, Youcef M. Rustum, William R. Greco, John F. Gaeta, Robert P. Huben, Inhibition of Implantation of Murine Bladder Tumor by Thiotepa in Cauterized Bladder Journal of Urology. ,vol. 142, pp. 1589- 1593 ,(1989) , 10.1016/S0022-5347(17)39174-7
Y. Fujii, S. Kawakami, F. Koga, T. Nemoto, K. Kihara, Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJUI. ,vol. 92, pp. 559- 562 ,(2003) , 10.1046/J.1464-410X.2003.04415.X
Mike Shelley, J B Court, H Kynaston, Timothy J Wilt, Reg Fish, Malcolm Mason, Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer. Cochrane Database of Systematic Reviews. ,vol. 2000, ,(2000) , 10.1002/14651858.CD001986
Doherty, Trendell-Smith, Stirling, Rogers, Bellringer, Perivesical fat necrosis after adjuvant intravesical chemotherapy. BJUI. ,vol. 83, pp. 420- 423 ,(2001) , 10.1046/J.1464-410X.1999.00951.X
Farhang Rabbani, Michael Perrotti, Paul Russo, Harry W. Herr, Upper-Tract Tumors After an Initial Diagnosis of Bladder Cancer: Argument for Long-Term Surveillance Journal of Clinical Oncology. ,vol. 19, pp. 94- 100 ,(2001) , 10.1200/JCO.2001.19.1.94
Sven Oehlschläger, A. Loessnitzer, Michael Froehner, Oliver W. Hakenberg, Andreas Manseck, Manfred P. Wirth, Distal ureteral stenosis after early adjuvant intravesical mitomycin C application for superficial bladder cancer. Urologia Internationalis. ,vol. 70, pp. 74- 76 ,(2003) , 10.1159/000067698